Screener
Twist Bioscience Corporation TWST Q3 2026 earnings
Reported August 3, 2026 · Before market open
Revenue$118.4MBeat by $3.9M
EPS-$0.56Miss by $0.05
Revenue estimate$114.5M
EPS estimate-$0.51
“Well into our final quarter of the fiscal year, we remain confident in our trajectory and continue to expect to achieve adjusted EBITDA breakeven this quarter. That milestone is not the destination. It's the foundation for delivering disciplined execution and profitable growth as we move through fiscal 2027.”
Next report
Nov 13, 2026 (in 2 months)Revenue estimate$123.6M
EPS estimate-$0.44
Valuation & ratios
Valuation
as of 09/17/26Versus estimates
Revenue
Diluted EPS
FAQ
- When did Twist Bioscience Corporation report Q3 2026 earnings?
- Twist Bioscience Corporation (TWST) reported Q3 2026 earnings on August 3, 2026 before market open.
- What were Twist Bioscience Corporation's Q3 2026 revenue and EPS?
- Twist Bioscience Corporation reported revenue of $118.4M and eps of $-0.56 for Q3 2026.
- Did Twist Bioscience Corporation beat estimates in Q3 2026?
- Revenue beat the consensus estimate of $114.5M by $3.9M. EPS missed the consensus estimate of $-0.51 by $0.05.
- How did Twist Bioscience Corporation's Q3 2026 results compare year-over-year?
- Compared to the same quarter a year prior, revenue grew 23.3% from $96.1M a year earlier and eps declined 19.1% from $-0.47.
- Where can I find Twist Bioscience Corporation's Q3 2026 SEC filings?
- You can read the 8-K earnings release (0001581280-26-000044) and the 10-Q periodic report (0001581280-26-000047) directly on SEC EDGAR. The filing index links above go to sec.gov.
